Authors: | Ribas, A.; Robert, C.; Hodi, F. S.; Wolchok, J. D.; Joshua, A. M.; Hwu, W. J.; Weber, J. S.; Zarour, H. M.; Kefford, R.; Loboda, A.; Albright, A.; Kang, S. P.; Ebbinghaus, S.; Yearley, J.; Murphy, E.; Nebozhyn, M.; Lunceford, J. K.; McClanahan, T.; Ayers, M.; Daud, A. |
Abstract Title: | Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature |
Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
Journal Title: | Journal of Clinical Oncology |
Volume: | 33 |
Issue: | 15 Suppl. |
Meeting Dates: | 2015 May 29-Jun 2 |
Meeting Location: | Chicago, IL |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2015-05-20 |
Language: | English |
ACCESSION: | WOS:000358036900635 |
PROVIDER: | wos |
DOI: | 10.1200/JCO.2015.33.15_suppl.3001 |
Notes: | Meeting Abstract: 3001 -- Source: Wos |